Glassy cell carcinoma of the uterine cervix

Journal of Surgical Oncology

Volumn 72, Issue 4, 1999, Pages 206-210

  Piura, Benjamin ^a   Rabinovich, Alex ^a   Meirovitz, Mihai ^a   Yanai Inbar, Ilana ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adenosquamous carcinoma; Chemoradiotherapy; Pelvic radiotherapy; Radical hysterectomy; Survival; Vaginal bleeding

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA; VAGINA BLEEDING;

EID: 0033408481     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9098(199912)72:4<206::aid-jso5>3.0.co;2-%23     Document Type: Article

References (27)

1. Glucksmann A, Cherry CP: Incidence, histology, and response to radiation of mixed carcinomas (adenocarcinomas) of the uterine cervix. Cancer 1956;9:971-979.
2. Littman P, Clement P, Henriksen B, et al.: Glassy cell carcinoma of the cervix. Cancer 1976;37:2238-2246.
3. Nahhas WA, Abt AB, Mortel R: Stage IB glassy cell carcinoma of the cervix with ovarian metastasis. Gynecol Oncol 1977;5:87-91.
4. Seltzer V, Sail S, Castadot MJ, et al.: Glassy cell cervical carcinoma. Gynecol Oncol 1979;8:141-149.
5. Paulsen SM, Hansen KC, Nielsen VT: Glassy-cell carcinoma of the cervix: Case report with a light and electron microscopy study. Ultrastruct Pathol 1980;1:377-384.
6. Richard L, Gurnalick M, Ferenczy A: Ultrastructure of glassy cell carcinoma of cervix. Diagn Gynecol Obstet 1981;3:31-38.
7. Zaino RJ, Nahhas WA, Mortel R: Glassy cell carcinoma of the uterine cervix. An ultrastructural study and review. Arch Pathol Lab Med 1982;106:250-254.
8. Fu YS, Regan JW, Hsiu JG, et al.: Adenocarcinoma and mixed carcinoma of the uterine cervix. I. A clinico-pathologic study. Cancer 1982;49:2560-2570.
9. Maier RC, Norris HJ: Glassy cell carcinoma of the cervix. Obstet Gynecol 1982;60:219-224.
10. Johnston GA, Azizi F, Jones HA: Glassy cell carcinoma of the cervix: Report of three cases. J Natl Med Assoc 1982;74:361-363.
11. Ulbright TM, Gersell DJ: Glassy cell carcinoma of the uterine cervix. A light and electron microscope study of five cases. Cancer 1983;51:2255-2263.
12. Pak HY, Yokota SB, Paladugu RA, et al.: Glassy cell carcinoma of the cervix. Cytologic and clinicopathologic analysis. Cancer 1983;52:307-312.
13. Tanaka T, Ohbayashi F, Shima H, et al.: Glassy cell carcinoma of the uterine cervix. Pathol Res Pract 1984;178:389-392.
14. Nunez C, Abdul-Karim FW, Somrak TM: Glassy-cell carcinoma of the uterine cervix. Cytopathologic and histopathologic study of five cases. Acta Cytol 1985;29:303-309.
15. Tamimi HK, Ek M, Hesla J, et al.: Glassy cell carcinoma of the cervix redefined. Obstet Gynecol 1988;71:837-841.
16. Reisinger SA, Palazzo JP, Talerman A, et al.: Stage IB glassy cell carcinoma of the cervix diagnosed during pregnancy and recurring in a transposed ovary. Gynecol Oncol 1991;42:86-90.
17. Costa MJ, Kenny MB, Hewan-Lowe K, et al.: Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologie, ultrastructural, immunohistochemical, and clinical findings. Am J Clin Pathol 1991;96:520-528.
18. Lotocki RJ, Krepart GV, Paraskevas M. et al.: Glassy cell carcinoma of the cervix: A bimodal treatment strategy. Gynecol Oncol 1992;44:254-259.
19. Atlas I, Gajewski W, Falkenberry S, et al.: Absence of estrogen and progesterone receptors in glassy cell carcinoma of the cervix. Obstet Gynecol 1998;91:136-138.
20. Piver MS, Rutledge FN, Smith PJ: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44:265-270.
21. Shepherd JH: Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989;96:889-892.
22. Piura B, Dgani R, Yanai-Inbar I, et al.: Adenocarcinoma of the uterine cervix: A study of 37 cases. J Surg Oncol 1996;61:249-255.
23. Morris M, Eifel PJ, Lu J, et al.: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
24. Rose PG, Bundy BN, Watkins EB, et al.: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
25. Keys HM, Bundy BN, Stehman FB, et al.: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. N Engl J Med 1999;340:1154-1161.
26. Peters WA III, Liu PY, Barret R, et al.: Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III inter-group study. Presented at the 30th annual meeting of the Society of Gynecologic Oncologists, San Francisco, 20-24 March, 1999.
27. Whitney CW, Sause W, Bundy BN, et al.: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages HB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999; 17:1339-1348.